(Q44028357)

29 November 2017

title

Acamprosate decreases the induction of tolerance and physical dependence in morphine-treated mice (English)

1 reference

29 November 2017

1 reference

Jacqueline Sepúlveda

1

1 reference

29 November 2017

Andrea Ortega

series ordinal

2

1 reference

29 November 2017

Gladys Zapata

series ordinal

3

1 reference

29 November 2017

Enrique Contreras

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

European Journal of Pharmacology

29 November 2017

published in

1 reference

29 November 2017

volume

445

1 reference

29 November 2017

issue

1-2

1 reference

29 November 2017

page(s)

87-91

1 reference

Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Outflow of endogenous aspartate and glutamate from the rat spinal dorsal horn in vitro by activation of low- and high-threshold primary afferent fibers. Modulation by μ-opioids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Molecular and cellular basis of addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Comparative effects of NG-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Riluzole decreases the abstinence syndrome and physical dependence in morphine-dependent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901767-3

10.1016/S0014-2999(02)01767-3

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference